145 related articles for article (PubMed ID: 29937558)
1. Polymorphism of FAS and FAS Ligand Genes in Alopecia Areata: A Case-control Study in Egyptian Population.
Seleit I; Bakry OA; Gayed EAE; Gawad AED
Indian J Dermatol; 2018; 63(3):220-226. PubMed ID: 29937558
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
Kalkan G; Ateş O; Karakuş N; Sezer S
Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
[TBL] [Abstract][Full Text] [Related]
3. Overlapping and Distinct
Tabatabaei-Panah PS; Moravvej H; Arian S; Fereidonpour I; Behravesh N; Atoon A; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2020 Feb; 49(1-2):204-214. PubMed ID: 31741398
[TBL] [Abstract][Full Text] [Related]
4. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of
Asgari R; Yari K; Mansouri K; Bakhtiari M
Biomed Rep; 2018 Apr; 8(4):391-395. PubMed ID: 29541461
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.
Fan X; Shangguan L; Li M; Li CY; Liu B
Br J Dermatol; 2010 Aug; 163(2):340-4. PubMed ID: 20394629
[TBL] [Abstract][Full Text] [Related]
8. Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.
Erdogan M; Kulaksizoglu M; Ganidagli S; Berdeli A
J Endocrinol Invest; 2017 Jan; 40(1):77-82. PubMed ID: 27572459
[TBL] [Abstract][Full Text] [Related]
9. IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
Loureiro Dos Reis MM; Queiroz MAF; da Silva BCM; da Silva Duarte AJ; Casseb J; Arganaraz GA; Vallinoto ACR; Argañaraz ER
J Med Virol; 2020 Aug; 92(8):1148-1157. PubMed ID: 31825106
[TBL] [Abstract][Full Text] [Related]
10. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
11. Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis.
Gil-Quiñones SR; Sepúlveda-Pachón IT; Sánchez Vanegas G; Gutierrez-Castañeda LD
PLoS One; 2021; 16(11):e0258499. PubMed ID: 34735462
[TBL] [Abstract][Full Text] [Related]
12. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş; Berdeli A
Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
[TBL] [Abstract][Full Text] [Related]
14. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
15. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG
J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
19. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
20. FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection.
Mohammadi A; Tajik N; Shah-Hosseini A; Alavian SM; Sharifi Z; Jarahi L
Hepat Mon; 2015 Oct; 15(10):e26490. PubMed ID: 26587033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
